New solutions for studying RNA for infectious disease, oncology, and genetic disease research   We are excited for the launch of the expanded RNA Library Preparation product portfolio. The new enhancements deliver solutions for studying RNA that provide rapid turn-around time, broad study flexibility and sequencing scalability while delivering exceptional data quality for infectious disease, oncology, and [...]

Advanced AI-discovery platform Imagia EVIDENS™ to link analysis of genomic data to patient outcomes for reproducible data-driven precision medicine research MONTRÉAL -  Imagia, a leading healthcare AI company that unites healthcare expertise and advanced artificial intelligence technology, and Illumina, a global leader in DNA sequencing and analysis, today announced a partnership to investigate how genomics, clinical data and imaging will [...]

Porvair Sciences announce Microlute™ CP - a new generation of Solid Phase Extraction (SPE) 96-well microplates and cartridges that take SPE to a new level of performance by enhancing the reproducibility of analyte extraction and recovery from biological, environmental and chemical samples. Unlike traditional loose-packed SPE methods, Microlute CP uses a hybrid structure, a solid [...]

In what is planned to be an ever-growing resource for laboratory informatics professionals everywhere, CSols, Inc., the premier laboratory informatics consultancy, has launched CSols University, with its first-ever online course, Creating a Lab Informatics Risk Assessment. This one-hour course is the first to launch this summer, with more to come in the near future. CSols University was [...]

Company launches Q Line sequencing portfolio for users in regulated settings  Oxford Nanopore today announced its pathway towards providing products for the diagnostics and other regulated markets. Products for customers in regulated environments  Q line, launched today, is designed to support users who wish to develop tests based on nanopore sequencing, for deployment in their own environments. The ISO9001-qualified Q [...]

Almelo, The Netherlands:  Malvern Panalytical, a world-leading analytical instrumentation and automation solutions provider, and part of Spectris plc, has welcomed Mr Mark Fleiner as its new president.  Mr Fleiner, who was previously Business Group Director of the Industrial Solutions Division of Spectris plc, moved into his new role at Malvern Panalytical on 1 May 2020. [...]

Comprehensive Panel Designed to Provide Molecular Characterization of Aggressive Lymphomas TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-launch introduction of its new HTG EdgeSeq Pan B-Cell Lymphoma Panel, which is expected to be commercially available for purchase in kit [...]

Eurofins Technologies, a supplier of test kits and systems for laboratory analyses, announces that its ELISA assay (enzyme-linked immunosorbent assay) for the detection of gluten, SENSISpec Ingezim Gluten R5, has been granted AOAC Research Institute Performance Tested MethodsSM status (AOAC Cert. No. 052005) for use with gluten-free bread, oat flour and stainless steel surfaces. The assay was developed by Eurofins Ingenasa, a biotechnology [...]

Vienna, Austria, and San Diego, CA, USA, June 17, 2020 – Lexogen, a transcriptomics and Next Generation Sequencing company, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis and collaboration tools, announced availability for the QuantSeq 3’ mRNA-Seq data analysis pipeline on ROSALIND™, the globally recognized discovery platform for scientists and researchers. The partnership enhances QuantSeq 3’ [...]

GSv9™ is Lonza’s newly launched chemically defined media and feeds platform, specifically developed to enhance the performance of the GS Gene Expression System® for optimized recombinant protein production The GSv9™ Media, Feeds and Operating parameters are simple to implement and highly robust, maximizing product yields and improving consistency to meet the scalability needs of biopharmaceutical [...]